Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 88601-88650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04959903
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
PHASE1/PHASE2Recruiting
36 participants
Started: Mar 31, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05158413
High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety
NARecruiting
40 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05525767
Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer
PHASE4Recruiting
75 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05271110
Surgery for Liver Metastases From PDAC
NANot yet recruiting
64 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2027
1 condition9 sponsors1 location
NCT05642182
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
PHASE1Recruiting
90 participants
Started: Mar 31, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor3 locations
NCT05662761
Assessment of the Relationship Between Severity of Chronic Venous Obstruction and Venous Claudication
N/ARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05218499
Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
PHASE2/PHASE3Active, not recruiting
400 participants
Started: Mar 31, 2022 · Completed: Nov 28, 2025
1 condition1 sponsor109 locations
NCT05195034
Effect of Dexmedetomidine on Postoperative Delirium After Awake Craniotomies
NARecruiting
210 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05129150
Cognitive Disorders and Brain Pulse
N/ARecruiting
300 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2031
1 condition1 sponsor1 location
NCT05206812
Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in Operable Non-small Cell Lung Cancer (NSCLC) (MIRACLE)
PHASE2Not yet recruiting
25 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05142605
Evaluation of Grief Therapy Approaches for Bereaved Parents
NARecruiting
415 participants
Started: Mar 31, 2022 · Completed: May 31, 2026
3 conditions2 sponsors4 locations
NCT05243693
Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma
PHASE2Recruiting
30 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06239415
PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS)
N/ARecruiting
250 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2024
1 condition2 sponsors1 location
NCT05272969
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease
N/ARecruiting
95 participants
Started: Mar 31, 2022 · Completed: Sep 3, 2024
4 conditions1 sponsor1 location
NCT05267327
A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast
N/ANot yet recruiting
1,500 participants
Started: Mar 31, 2022 · Completed: May 31, 2026
1 condition2 sponsors0 locations
NCT05278975
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
PHASE1/PHASE2Recruiting
186 participants
Started: Mar 31, 2022 · Completed: Apr 1, 2025
6 conditions1 sponsor10 locations
NCT05101187
Olorofim Aspergillus Infection Study
PHASE3Recruiting
225 participants
Started: Mar 31, 2022 · Completed: Nov 1, 2026
1 condition3 sponsors140 locations
NCT05131893
Neoadjuvant Treatment of Breast Cancer
N/ANot yet recruiting
300 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
130 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2026
16 conditions2 sponsors9 locations
NCT05292768
Are Mast Cells Involved in Autoinflammatory Diseases
N/ANot yet recruiting
590 participants
Started: Mar 31, 2022 · Completed: Oct 31, 2026
6 conditions2 sponsors1 location
NCT05290857
Anticoagulation After GI Bleeding Pilot Study and Registry
NARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05287308
Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
NANot yet recruiting
500 participants
Started: Mar 31, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05238064
Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL
PHASE1/PHASE2Not yet recruiting
30 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor0 locations
NCT05323357
Bern Human Organoid-Study to Study Host-microbe Interaction
N/ARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT05349318
Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease
NARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2025
4 conditions1 sponsor1 location
NCT05300451
Daratumumab in HLA Desensitization Prior to Transplantation
PHASE2Enrolling by invitation
6 participants
Started: Mar 31, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT05256290
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
PHASE1/PHASE2Active, not recruiting
200 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2026
10 conditions1 sponsor41 locations
NCT06428487
Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer
PHASE2Recruiting
30 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04979052
Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
PHASE2Recruiting
200 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors6 locations
NCT05237232
Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children
N/ARecruiting
30 participants
Started: Mar 31, 2022 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT05266313
Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy
NAActive, not recruiting
135 participants
Started: Mar 31, 2022 · Completed: Mar 26, 2025
1 condition1 sponsor1 location
NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
36 participants
Started: Mar 31, 2022 · Completed: Feb 24, 2026
130 conditions1 sponsor1 location
NCT06141408
PrEP Intervention in Prince George's County, Maryland
NARecruiting
120 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05607472
Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island
NAActive, not recruiting
258 participants
Started: Mar 30, 2022 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT04791488
Impact of Hyperoxia and Involvement of the Immune System in Diving Accident
NARecruiting
265 participants
Started: Mar 30, 2022 · Completed: Mar 30, 2028
1 condition1 sponsor1 location
NCT05383755
Digital Intervention to Address Stigma Among Pregnant Adolescents Living With HIV
NAActive, not recruiting
198 participants
Started: Mar 30, 2022 · Completed: May 30, 2024
5 conditions4 sponsors1 location
NCT05215769
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer
NAActive, not recruiting
243 participants
Started: Mar 30, 2022 · Completed: Jul 31, 2026
8 conditions2 sponsors4 locations
NCT05451628
Anatomy-Based Fitting in Unexperienced Cochlear Implant Users
NARecruiting
40 participants
Started: Mar 30, 2022 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT05616507
Oligo-Fucoidan Decrease Lung Radiation Damage
NARecruiting
100 participants
Started: Mar 30, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04698031
Efficacy of Clopidogrel on Incidence of Silent Brain Infarction
PHASE4Recruiting
125 participants
Started: Mar 30, 2022 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT05257993
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
PHASE1Recruiting
30 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT05591547
Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen
PHASE2Active, not recruiting
91 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT04582383
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
PHASE4Active, not recruiting
350 participants
Started: Mar 30, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor18 locations
NCT04397003
Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
PHASE2Active, not recruiting
6 participants
Started: Mar 30, 2022 · Completed: Sep 30, 2029
1 condition3 sponsors1 location
NCT05118854
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
PHASE2Recruiting
27 participants
Started: Mar 30, 2022 · Completed: Oct 20, 2027
1 condition2 sponsors2 locations
NCT05145764
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
PHASE2Recruiting
120 participants
Started: Mar 30, 2022 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT05950711
Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study
PHASE4Active, not recruiting
21 participants
Started: Mar 30, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05312879
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
PHASE2/PHASE3Recruiting
466 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor314 locations
NCT05223387
Tissue Level vs Bone Level Implants for Plural Restorations : a Multicentre Randomised Controlled Trial
NAActive, not recruiting
40 participants
Started: Mar 30, 2022 · Completed: Jul 18, 2027
2 conditions1 sponsor3 locations
NCT04372615
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
PHASE2Recruiting
116 participants
Started: Mar 30, 2022 · Completed: Sep 30, 2028
2 conditions1 sponsor39 locations